SE430250B - Forfarande for framstellning av kalciumsaltet av 5-alkoxi-pikolinsyra - Google Patents

Forfarande for framstellning av kalciumsaltet av 5-alkoxi-pikolinsyra

Info

Publication number
SE430250B
SE430250B SE7710933A SE7710933A SE430250B SE 430250 B SE430250 B SE 430250B SE 7710933 A SE7710933 A SE 7710933A SE 7710933 A SE7710933 A SE 7710933A SE 430250 B SE430250 B SE 430250B
Authority
SE
Sweden
Prior art keywords
alcoxy
preparing
procedure
calcium salt
picolic acid
Prior art date
Application number
SE7710933A
Other languages
English (en)
Other versions
SE7710933L (sv
Inventor
T Koeda
T Tsuruoka
U Shibata
H Asaoka
M Hachisu
O Itoh
Y Sekizawa
S Inouye
T Niida
Original Assignee
Meiji Seika Kaisha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Kaisha filed Critical Meiji Seika Kaisha
Publication of SE7710933L publication Critical patent/SE7710933L/sv
Publication of SE430250B publication Critical patent/SE430250B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7710933A 1976-09-30 1977-09-29 Forfarande for framstellning av kalciumsaltet av 5-alkoxi-pikolinsyra SE430250B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11664176A JPS5344572A (en) 1976-09-30 1976-09-30 5-alkoxy-picolic acid, its preparation and hypotensives containing the same

Publications (2)

Publication Number Publication Date
SE7710933L SE7710933L (sv) 1978-03-31
SE430250B true SE430250B (sv) 1983-10-31

Family

ID=14692226

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7710933A SE430250B (sv) 1976-09-30 1977-09-29 Forfarande for framstellning av kalciumsaltet av 5-alkoxi-pikolinsyra

Country Status (9)

Country Link
US (1) US4189489A (sv)
JP (1) JPS5344572A (sv)
BE (2) BE859198A (sv)
CA (1) CA1099720A (sv)
DE (1) DE2743944C3 (sv)
FR (1) FR2366279A1 (sv)
GB (1) GB1545358A (sv)
NL (1) NL179477C (sv)
SE (1) SE430250B (sv)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1115709A (en) * 1978-03-24 1982-01-05 Uichi Shibata 5-substituted-hydroxy picolinic acid derivatives
US4260620A (en) * 1979-10-26 1981-04-07 Ciba-Geigy Corporation 2-Pyridinecarboxylic acids
CN109646437B (zh) * 2017-10-12 2022-04-15 四川好医生攀西药业有限责任公司 具有促进创面愈合作用的6-羟甲基吡啶-3-醇及应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3291805A (en) * 1965-01-28 1966-12-13 Squibb & Sons Inc Method for the production of hydroxypicolinic acid
US3519717A (en) * 1968-01-17 1970-07-07 Schering Corp Novel method for lowering high blood pressure and compositions therefor
US3697531A (en) * 1971-02-25 1972-10-10 Sterling Drug Inc N,n{40 -alkylenebis(pyridine-carboxamides)
BE795518A (fr) * 1972-02-17 1973-08-16 Ciba Geigy Nouveaux composes pyridiniques et leurs procedes de preparation
SE385883B (sv) * 1972-04-10 1976-07-26 Ciba Geigy Ag Forfarande for framstellning av nya pyridinkarbonsyraestrar
CH602110A5 (sv) * 1974-04-18 1978-07-31 Hoffmann La Roche
GB1502055A (en) * 1975-06-30 1978-02-22 Meiji Seika Kaisha 3-substituted-2(1h)pyridon-6-carboxylic acids and processes for preparing the same

Also Published As

Publication number Publication date
SE7710933L (sv) 1978-03-31
DE2743944A1 (de) 1978-04-06
DE2743944C3 (de) 1981-07-16
NL7710653A (nl) 1978-04-03
US4189489A (en) 1980-02-19
NL179477C (nl) 1986-09-16
BE859198A (fr) 1978-01-16
FR2366279A1 (fr) 1978-04-28
JPS5344572A (en) 1978-04-21
FR2366279B1 (sv) 1981-10-16
DE2743944B2 (de) 1980-09-11
GB1545358A (en) 1979-05-10
CA1099720A (en) 1981-04-21
BE866977R (fr) 1978-09-01
NL179477B (nl) 1986-04-16

Similar Documents

Publication Publication Date Title
TR19755A (tr) Tereftalik asidin hazirlanmasina mahsus usul
SE441827B (sv) Forfarande for framstellning av fenoxiaminopropanoler
AR209607A1 (es) Procedimiento de preparacion de derivados de acido 2,3-d oxo-1-piperazino-carbonilamino-acetamido-penicilanico o 2,3-dioxo-1-piperazinocarbonilamino-acetamido-delta3-cefem-4-carboxilico
NO774404L (no) Fremgangsmaate for fremstilling av dimetyleter
NO772652L (no) Fremgangsm}te til fremstilling av fosfonsyrederivater
NO771578L (no) Fremgangsmaate for fremstilling av di-n-propyleddiksyre
SE441354B (sv) Forfarande for framstellning av meta-fenoxibensaldehyd
SE435387B (sv) Forfarande for framstellning av antracyklinglykosider
NO143992C (no) Fremgangsmaate for fremstilling av heksanitrostilben
NO143384C (no) Fremgangsmaate for fremstilling av stivelseloesning
SE7707621L (sv) Forfarande for framstellning av xyloslosning
SE7707471L (sv) Forfarande for framstellning av 5-m-tolyloxiuracil
NO774067L (no) Fremgangsmaate for fremstilling av cellulosemasse
NO146365C (no) Framgangsmaate for framstilling av oppkullete svampjernsbriketter
SE7712218L (sv) Forfarande for framstellning av 4a-aryloktahydro-1h-2-pyrindiner
NO152451C (no) Fremgangsmaate for fremstilling av fosfonsyrederivater
SE421787B (sv) Forfarande for framstellning av kvadratsyra
NO773622L (no) Fremgangsmaate til fremstilling av tereftalsyre
SE435380B (sv) Forfarande for framstellning av kinazolinforeningar
SE430250B (sv) Forfarande for framstellning av kalciumsaltet av 5-alkoxi-pikolinsyra
SE434743B (sv) Forfarande for framstellning av (2-pyrimidinyl-tio)-alkansyraamider
SE7709142L (sv) Forfarande for framstellning av 1-aryloxi-3-amino-propan-2-oler
SE7702071L (sv) Forfarande for framstellning av sulfoacetaler
SE7709636L (sv) Forfarande for framstellning av 4-oxokapronitril
NO774147L (no) Fremgangsmaate for fremstilling av kinazolinonforbindelser

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7710933-8

Effective date: 19940410

Format of ref document f/p: F